53Biologics — No stage disclosed

Valladolid-based GMP biomanufacturing company 53Biologics raised an undisclosed amount in a round led by European private equity firm Ren Life Sciences, with long-standing investor Inveready participating. The capital funds expansion of GMP capacity, service consolidation and international growth; no stage was disclosed.